文献速递口腔修复与种植口腔颌面外科

头颈癌治疗后种植修复的长期临床回顾性评估

Retrospective long-term clinical evaluation of implant-prosthetic rehabilitations after head and neck cancer therapy.
PubMed 文献 · Clin Oral Implants Res · 2021-02-07

本研究回顾性评估头颈癌(HNC)切除术后(伴或不伴辅助放疗)种植修复的临床与患者报告结局,并与健康对照组比较。种植体存活率HNC-TR为98.1%、HNC-TR/RT为98.2%、对照组为100.0%,修复体无失败;放疗组mPI和mBI显著高于对照组,前庭沟成形术可显著降低mBI和PD,患者更偏好杆卡优于Locator附着体。

要点

  • 头颈癌术后种植体长期存活率高,放疗未显著降低种植体存活率。
  • 放疗组种植体周围改良菌斑指数和出血指数显著高于健康对照。
  • 前庭沟成形术可显著改善放疗患者种植体周围出血和探诊深度。

核心结论

  • 头颈癌治疗后种植修复在种植体和修复体水平均观察到高存活率。
  • 软组织移植可稳定放疗患者的种植体周围黏膜。
  • 在固位和咀嚼能力方面,患者更偏好杆卡附着体而非Locator附着体。

研究设计与样本

  • 回顾性研究,共纳入28名女性和29名男性。
  • 参与者共接受322枚种植体,最终支持79例修复重建。
  • 设健康对照组,采用相同重建方案。

主要发现

  • 平均随访81.2±50.3个月,种植体存活率HNC-TR为98.1%、HNC-TR/RT为98.2%、对照组为100.0%,HNC组共4枚种植体失败。
  • HNC-TR/RT组mPI和mBI显著高于对照组。
  • HNC-TR/RT组内,前庭沟成形术显著降低mBI和PD值。
  • 修复体水平无失败。
  • 杆卡修复体总体VAS评分高于Locator固位修复体,HNC-TR/RT组OHIP G14值升高。

临床怎么用

  • 头颈癌术后患者可考虑种植修复,但需加强种植体周围软组织监测。
  • 对放疗患者行前庭沟成形术可能有助于改善种植体周围软组织健康。
  • 选择附着体类型时可参考患者对固位和咀嚼能力的偏好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess clinical and patient-reported outcomes of implant-prosthetic rehabilitations in patients with a history of head-neck cancer (HNC), treated with tumor resection without (TR) or with adjuvant radiotherapy (TR/RT). A healthy cohort rehabilitated with the same reconstructive protocols served as control group (C). MATERIALS AND METHODS: A total of 28 women and 29 men were considered in the present retrospective study. Participants received 322 implants, finally supporting 79 prosthetic reconstructions. Primary outcome was the assessment of implant and prosthetic survival rates. Furthermore peri-implant soft tissue parameters (attached peri-implant mucosa, AM; modified bleeding and plaque indices, mBI/mPI; probing depth, PD) and prosthetic technical complications were documented. Patient-reported outcome measures (PROMs) by means of visual analog scales (VAS) and the Oral Health Impact Profile German 14 form (OHIP G14) were collected. For statistical purposes Chi-square and Mann-Whitney-U-Test were adapted. RESULTS: After a mean follow-up of 81.2 ± 50.3 months, implant survival rate was 98.1% (HNC-TR), 98.2% (HNC-TR/RT) and 100.0% (C), respectively (four implants failed in the HNC groups). HNC-TR/RT showed significant higher mPI and mBI compared to C. Within HNC-TR/RT, vestibuloplasty significantly reduced mBI and PD values. No failures occurred at the prosthetic level. Overall, higher VAS scores were reported for bar- compared with Locator-retained prostheses. Furthermore, increased OHIP G14 values resulted for HNC-TR/RT. CONCLUSIONS: High survival rates on implant and prosthetic level were observed. The use of soft tissue grafts resulted in stabilization of the peri-implant mucosa in irradiated patients. In terms of retention and chewing ability, participants preferred bars over Locator attachments.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Pieralli S, Spies BC, Schweppe F, et al. Retrospective long-term clinical evaluation of implant-prosthetic rehabilitations after head and neck cancer therapy. Clin Oral Implants Res. 2021. PMID: 33501694. doi:10.1111/clr.13716

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。